Company
shattucklabs.com
Also known as Shattuck Labs, Inc
- Business model
- B2B
- Legal name
- Shattuck Labs, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Shattuck Labs is advancing DR3-targeting antibodies to raise the standard of care in IBD and other inflammatory, immune-mediated diseases.
Funding snapshot
- Total raised
- $165MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $83M2020-06-12
Funding rounds
- Round, 2020
- $83M2020-06-12, SEC form D sold, 32 investors
- Round, 2020
- $25.4M2020-01-31, SEC form D sold, 71 investors
- Round, 2018
- $46.6M2018-05-15, SEC form D sold, 62 investors
- Round, 2017
- $7M2017-03-24, SEC form D sold, 27 investors
- Round, 2016
- $3.4M2016-07-14, SEC form D sold, 25 investors
Loading relationship preview